ARCA biopharma, Inc.
ABIO
NASDAQ
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/7/2024
-
GuruFocus
9/28/2024
-
Zolmax
9/21/2024
-
Ticker Report
9/14/2024
-
Ticker Report
9/14/2024
-
GuruFocus
9/4/2024
-
Zolmax
9/4/2024
-
Ticker Report
9/3/2024
-
The Fly
9/2/2024
-
Ticker Report
9/2/2024
-
Zolmax
9/1/2024
-
Zolmax
8/30/2024
-
The Fly
8/30/2024
-
Ticker Report
8/29/2024
-
Globe Newswire
8/26/2024
-
The Fly
8/26/2024
-
Globe Newswire
8/23/2024
-
Seeking Alpha - Healthcare
8/23/2024
-
The Fly
8/23/2024
-
Globe Newswire
8/22/2024
-
Ticker Report
8/22/2024
-
Ticker Report
8/21/2024
-
Ticker Report
8/19/2024
-
Benzinga
8/16/2024
-
The Fly
8/16/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 1, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Oct 14 and 18 (est)
Price History
Beta
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
720 940 2200
Address
10170 Church Ranch Way
Westminster, CO 80021
Westminster, CO 80021
Country
Year Founded
--
Business Description
Sector
As of August 29, 2024, ARCA biopharma, Inc. was acquired by Oruka Therapeutics, Inc., in a reverse merger transaction. ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in...
more
